Rank 11 • Biotech & Discovery
Schrödinger
Develops a physics-based computational platform to accelerate molecule discovery for therapeutics and materials science.
Visit website- Signal Score
- 92.3
- Total raised
- $400M
- Stage
- Public
- Founded
- 1990
- Headquarters
- New York, USA
- Region
- North America
Their signal
As an established public pioneer, Schrodinger's physics-driven software is used by almost every major pharmaceutical firm, validating its core scientific and commercial utility.
Signal Score 92.3editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.